119 related articles for article (PubMed ID: 38369842)
1. [Effect of signal peptide optimized by site-directed mutagenesis on the function of chimeric antigen receptor T cells].
Liu Y; Li F; Dai H; Zhou R; Wang M; Gan S; Xu Y
Sheng Wu Gong Cheng Xue Bao; 2024 Feb; 40(2):573-584. PubMed ID: 38369842
[TBL] [Abstract][Full Text] [Related]
2. [Study on construction of c-Met specific CAR-T cells and its killing effect on non-small cell lung carcinoma].
Min JT; Zhang L; Long CR; Fan HL; Li ZZ
Zhonghua Zhong Liu Za Zhi; 2023 Apr; 45(4):322-329. PubMed ID: 37078213
[No Abstract] [Full Text] [Related]
3. Therapeutic effect of dual CAR-T targeting PDL1 and MUC16 antigens on ovarian cancer cells in mice.
Li T; Wang J
BMC Cancer; 2020 Jul; 20(1):678. PubMed ID: 32689954
[TBL] [Abstract][Full Text] [Related]
4. [Construction and in vitro verification of a new humanized anti-CD19 CAR-T cells with high affinity].
Zhang CX; Cheng H; Han X; Qi KM; Chen W; Wu QY; Cao J; Xu KL
Zhonghua Xue Ye Xue Za Zhi; 2018 Jun; 39(6):465-470. PubMed ID: 30032561
[No Abstract] [Full Text] [Related]
5. Comparative analysis and optimization of protocols for producing recombinant lentivirus carrying the anti-Her2 chimeric antigen receptor gene.
Yuan W; Chen J; Cao Y; Yang L; Shen L; Bian Q; Bin S; Li P; Cao J; Fang H; Gu H; Li H
J Gene Med; 2018 Jul; 20(7-8):e3027. PubMed ID: 29851200
[TBL] [Abstract][Full Text] [Related]
6. [Effect of Special Structure Bi-Specific Chimeric Antigen Receptor T Cell on Tumor Cells].
Liu C; Peng H; Zeng WJ; Li W; Chen KK; Li WT; Zeng GF; Liang X; Hu JY; Zhou M
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Dec; 30(6):1730-1740. PubMed ID: 36476896
[TBL] [Abstract][Full Text] [Related]
7. [Establishment of a cytokine release syndrome associated with chimeric antigen receptor T cell treatment in SCID/Beige mice model].
Shan JQ; Nan SF; Li F; Shen CY; Zhang Y
Zhonghua Zhong Liu Za Zhi; 2021 Dec; 43(12):1248-1254. PubMed ID: 34915632
[No Abstract] [Full Text] [Related]
8. CD19 Chimeric Antigen Receptor T Cells From Patients With Chronic Lymphocytic Leukemia Display an Elevated IFN-γ Production Profile.
Magalhaes I; Kalland I; Kochenderfer JN; Österborg A; Uhlin M; Mattsson J
J Immunother; 2018; 41(2):73-83. PubMed ID: 29315094
[TBL] [Abstract][Full Text] [Related]
9. [Optimization of CAR-T cell culture system and lentivirus transduction conditions].
Wang H; Pan J; Jiang D; Qu Y; Li Y; Li G; Chu Y; Zhang X; Xu G
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 May; 36(5):390-397. PubMed ID: 32696750
[TBL] [Abstract][Full Text] [Related]
10. [Functional investigation of chimeric antigen receptor T cells targeting LMP1 antigen].
He HZ; Xing YY; Zhang Y; Xu YX; Tian Z; Xing HY; Tang KJ; Rao Q; Wang JX; Wang M
Zhonghua Xue Ye Xue Za Zhi; 2022 Mar; 43(3):229-234. PubMed ID: 35405781
[No Abstract] [Full Text] [Related]
11. Construction of a new anti-CD19 chimeric antigen receptor and the anti-leukemia function study of the transduced T cells.
An N; Tao Z; Li S; Xing H; Tang K; Tian Z; Rao Q; Wang M; Wang J
Oncotarget; 2016 Mar; 7(9):10638-49. PubMed ID: 26840021
[TBL] [Abstract][Full Text] [Related]
12. [The Construction of ROR1 Targeting Chimeric Antigen Receptor Modified T Cells and Its Killing Effect for ROR1-positive Tumor Cells].
Chen Y; Mo ZM; Qin DY; Guo FC; Liao XL; Hu M; Chen Q; Wang YS
Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 Mar; 50(2):145-151. PubMed ID: 31106530
[TBL] [Abstract][Full Text] [Related]
13. [Preparation of CD52-targeted chimeric antigen receptor-modified T cells and their anti-leukemia effects].
Liu Y; Liu Y; Tang KJ; Chen ZQ; Mou JL; Xu YX; Xing HY; Tian Z; Rao Q; Wang M; Wang JX
Zhonghua Xue Ye Xue Za Zhi; 2022 Apr; 43(4):279-286. PubMed ID: 35680625
[No Abstract] [Full Text] [Related]
14. [Optimization of CD19 chimeric antigen receptor T cell establishment and observation of the killing effect in vitro and in vivo].
Ren CX; Chen XX; Zhao L; Tian Y; Xu KL; Zhao K
Zhonghua Xue Ye Xue Za Zhi; 2022 Jun; 43(6):506-512. PubMed ID: 35968595
[No Abstract] [Full Text] [Related]
15. Using Oncolytic Virus to Retask CD19-Chimeric Antigen Receptor T Cells for Treatment of Pancreatic Cancer: Toward a Universal Chimeric Antigen Receptor T-Cell Strategy for Solid Tumor.
Chen C; Park AK; Monroy I; Ren Y; Kim SI; Chaurasiya S; Priceman SJ; Fong Y
J Am Coll Surg; 2024 Apr; 238(4):436-447. PubMed ID: 38214445
[TBL] [Abstract][Full Text] [Related]
16. Construction and functional characterization of a fully human anti-CD19 chimeric antigen receptor (huCAR)-expressing primary human T cells.
Mirzaei HR; Jamali A; Jafarzadeh L; Masoumi E; Alishah K; Fallah Mehrjardi K; Emami SAH; Noorbakhsh F; Till BG; Hadjati J
J Cell Physiol; 2019 Jun; 234(6):9207-9215. PubMed ID: 30362586
[TBL] [Abstract][Full Text] [Related]
17. [Construction of CD19-CAR retroviral vector and modification of its transduction of human T-lymphocytes].
Wang Y; Tang G; Xu L; Ruan J; Cheng H; Zhou H; Hua Y; Hu X; Gu H; Qian B; Wang J; Yang J
Zhonghua Xue Ye Xue Za Zhi; 2015 Apr; 36(4):331-6. PubMed ID: 25916298
[TBL] [Abstract][Full Text] [Related]
18. Differences in the phenotypes and transcriptomic signatures of chimeric antigen receptor T lymphocytes manufactured
Niu A; Zou J; Hu X; Zhang Z; Su L; Wang J; Lu X; Zhang W; Chen W; Zhang X
Front Immunol; 2023; 14():1068625. PubMed ID: 37228617
[TBL] [Abstract][Full Text] [Related]
19. Turning the tables on cytomegalovirus: targeting viral Fc receptors by CARs containing mutated CH2-CH3 IgG spacer domains.
Proff J; Brey CU; Ensser A; Holter W; Lehner M
J Transl Med; 2018 Feb; 16(1):26. PubMed ID: 29422056
[TBL] [Abstract][Full Text] [Related]
20. IL-6/IFN-γ double knockdown CAR-T cells reduce the release of multiple cytokines from PBMCs in vitro.
Zhang H; Lv X; Kong Q; Tan Y
Hum Vaccin Immunother; 2022 Dec; 18(1):1-14. PubMed ID: 35049413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]